New formulation helps RNA vaccines withstand high temperatures
MIT engineers have found a way to stabilize the lipid nanoparticles used to deliver RNA vaccines, which could allow the vaccines to be more widely distributed.
MIT engineers have found a way to stabilize the lipid nanoparticles used to deliver RNA vaccines, which could allow the vaccines to be more widely distributed.
MIT chemical engineers found a way to rapidly produce lipid nanoparticles of varying sizes, which could make it easier to develop new vaccines and therapeutics.
Tracking down senescent cells, which accumulate as we age, could help diagnose age-related disorders and guide researchers working on new treatments.
Novel research expands scientific understanding of how RNA shapes the reading of genetic information.
In the new method, cells package and export their RNA, enabling researchers to sequence and analyze the RNA without killing the cells.
Led by Andee Wallace PhD ’20, Robigo uses cutting-edge biotechnology to engineer microbes to fight pests, reducing the need for harmful chemical pesticides.
This discovery points toward new combination strategies against cancer, and may explain the iron buildup seen in disorders such as early-onset Parkinson’s disease.
Using a modular kit, the MIT Edgerton Center is bringing a hands-on biology curriculum to Massachusetts’ second-largest school district.
In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.
Using immune-remodeling mRNA molecules, researchers generated T cells that can slow tumor growth and, in some cases, eradicate tumors.
His studies have shed light on the assembly instructions that govern ribosomes, the critical protein-building machines of the cell.
When genes are transcribed, they suppress or activate their neighbors, coupling expression between the two genes.
Researchers uncovered how cells selectively destroy certain microRNAs — key gene regulators — through a mechanism that requires two RNA signals working together.
By showing the problem derives from genetic mutations that lead to overexpression of a microRNA, MIT researchers’ study points to potential treatment.
Eliezer Calo’s studies of craniofacial malformations have yielded insight into protein synthesis and embryonic development.